KEVZARA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Sarilumab.
Product ID | 0024-5920_01aea597-9923-4257-9aa6-f6a5f33cf627 |
NDC | 0024-5920 |
Product Type | Human Prescription Drug |
Proprietary Name | KEVZARA |
Generic Name | Sarilumab |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2017-05-22 |
Marketing Category | BLA / BLA |
Application Number | BLA761037 |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | SARILUMAB |
Active Ingredient Strength | 150 mg/1.14mL |
Pharm Classes | Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-04-13 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA761037 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-04-13 |
Marketing Category | BLA |
Application Number | BLA761037 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-04-13 |
Ingredient | Strength |
---|---|
SARILUMAB | 150 mg/1.14mL |
SPL SET ID: | 827bc01c-d379-4266-a18c-c7f904b76af3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0024-5908 | KEVZARA | sarilumab |
0024-5910 | KEVZARA | sarilumab |
0024-5920 | KEVZARA | sarilumab |
0024-5922 | KEVZARA | sarilumab |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KEVZARA 87275074 5274968 Live/Registered |
Sanofi Biotechnology 2016-12-20 |
KEVZARA 86394577 4780600 Live/Registered |
SANOFI BIOTECHNOLOGY 2014-09-15 |